K

A

Amplitude Ventures

Crunchbase
Pitchbook
Crunchbase

Deals on record

6

Common Fundraising Type

Series B

F
Fluid Biomed

Medical device • Bioabsorbable stent

Amplitude Ventures logo
ShangBay Capital logo
METIS Innovative logo
LifeArc Ventures logo

Fluid Biomed Inc. is a medical device company developing the world's first bioabsorbable polymer-based stent for treating brain aneurysms.

Series A
$27M
12/16/2024
Article
E
Evommune

Biotechnology • Clinical Development

RA Capital Management logo
Verition Fund Management logo
Symbiosis logo
RTW Investments logo

Evommune, Inc. is a biotechnology company focused on developing treatments for chronic inflammatory diseases.

Series C
$115M
10/31/2024
Article
N
Nomic

Protein profiling • Proteomics

SR One logo
Real Ventures logo
Lux Capital logo
AVANT BIO logo

Nomic Bio specializes in advanced protein profiling to extend health spans through its nELISA™ platform.

Series B
$42M
09/17/2024
Article
R
Radiant Bio

Multabody™ platform • Oncology

Amplitude Ventures logo
Toronto Innovation Acceleration Partners logo
FACIT logo
Bill & Melinda Gates Foundation logo

Radiant Biotherapeutics develops innovative therapies using its proprietary Multabody™ platform to target oncology, inflammation, immunology, and infectious diseases.

Series A
$35M
09/11/2024
Article
A
Ability Biologics

Antibody Therapeutics • Preclinical Development

Amplitude Ventures logo
Fonds de solidarit FTQ logo
Page One Ventures logo
Charles River Laboratories logo

Ability Biologics is a biotech startup focused on creating next-generation antibody therapeutics for unmet medical needs using their proprietary AI platform, AbiLeap™.

Seed
$12M
12/06/2023
Article
T
Tentarix Biotherapeutics

Biotechnology • Protein Therapeutics

Samsara BioCapital logo
Amplitude Ventures logo
Versant Ventures logo
Gilead Sciences logo

Tentarix Biotherapeutics is a biotechnology company that uses its proprietary Tentacles™ platform to discover and develop multi-functional, conditional protein therapeutics.

Series B
$35M
09/06/2023
Article